Experts associated with the European Society of Cardiology task force for the management of COVID-19, in probing the pathophysiological mechanisms of the two-way relationship between cardiovascular diseases and COVID-19, remind us that SARS-CoV-2 binds to the angiotensin-converting enzyme (ACE) 2 receptor for entry into cells [24,25]. This evidence concerns the gene ACE and COVID-19.